
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Collagen-Hydroxyapatite Scaffold
Therapeutic Area : Undisclosed
Study Phase : Phase II
Recipient : University of Alabama at Birmingham
Deal Size : Inapplicable
Deal Type : Inapplicable
Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue
Details : Collagen-Hydroxyapatite Scaffold is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 02, 2018
Lead Product(s) : Collagen-Hydroxyapatite Scaffold
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Recipient : University of Alabama at Birmingham
Deal Size : Inapplicable
Deal Type : Inapplicable
